GB Patent

GB2205837A — Phosphorus-containing HMG-CoA reductase inhibitors

Assigned to ER Squibb and Sons LLC · Expires 1988-12-21 · 37y expired

What this patent protects

Patent listed against lomitapide-mesylate.

Drugs covered by this patent

Patent Metadata

Patent number
GB2205837A
Jurisdiction
GB
Classification
—
Expires
1988-12-21
Drug substance claim
No
Drug product claim
No
Assignee
ER Squibb and Sons LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.